HC Wainwright & Co. analyst Joseph Pantginis downgrades Humanigen (NASDAQ:HGEN) from Buy to Neutral.
Read Why Aeglea BioTherapeutics Shares Are Skyrocketing Today?
The European Medicines Agency (EMA) has validated Aeglea BioTherapeutics Inc’s (NASDAQ:AGLE) marketing application seeking approval for pegzilarginase for the treatment of…